These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25359383)

  • 61. Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of Serbian patients with primary and secondary antiphospholipid syndrome.
    Djokovic A; Stojanovich L; Kontic M; Stanisavljevic N; Radovanovic S; Marisavljevic D
    Isr Med Assoc J; 2014 Mar; 16(3):162-7. PubMed ID: 24761704
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH.
    Devreese KMJ; Ortel TL; Pengo V; de Laat B;
    J Thromb Haemost; 2018 Apr; 16(4):809-813. PubMed ID: 29532986
    [No Abstract]   [Full Text] [Related]  

  • 63. The concomitant presence of lupus anticoagulant, anticardiolipin and anti-beta2-glycoprotein i antibodies could be associated with acquired activated protein c resistance in non-systemic lupus erythematosus patients.
    Gennari L; Blanco A; Alberto MF; Grosso S; Lazzari MA
    Br J Haematol; 2003 May; 121(3):527-9. PubMed ID: 12716380
    [No Abstract]   [Full Text] [Related]  

  • 64. IgM, but not IgA rheumatoid factor interferes with anti-cardiolipin and antiβ2 glycoprotein I measurements: a quantitative analysis.
    Lakos G; Teodorescu M
    Lupus; 2011 May; 20(6):614-9. PubMed ID: 21436214
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Anti-beta 2-glycoprotein I antibody testing in patients with antiphospholipid syndrome.
    Cabral AR; Alarcón-Segovia D
    Br J Rheumatol; 1997 Nov; 36(11):1235. PubMed ID: 9402876
    [No Abstract]   [Full Text] [Related]  

  • 66. Prevalence and clinical usefulness of antiphospholipid and anticofactor antibodies in different Spanish preeclampsia subsets.
    Ferrer-Oliveras R; Llurba E; Cabero-Roura L; Alijotas-Reig J
    Lupus; 2012 Mar; 21(3):257-63. PubMed ID: 22065091
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Non-Criteria or Seronegative Obstetric Antiphospholipid Syndrome?
    Jara LJ; Medina G; Cruz-Cruz P; Olivares-Rivera J; Duarte-Salazar C; Saavedra MA
    Isr Med Assoc J; 2017 Jun; 19(6):382-386. PubMed ID: 28647939
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays.
    Alarcon-Segovia D; Mestanza M; Cabiedes J; Cabral AR
    J Rheumatol; 1997 Aug; 24(8):1545-51. PubMed ID: 9263149
    [TBL] [Abstract][Full Text] [Related]  

  • 70. β2-Glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome.
    Tanimura K; Jin H; Suenaga T; Morikami S; Arase N; Kishida K; Hirayasu K; Kohyama M; Ebina Y; Yasuda S; Horita T; Takasugi K; Ohmura K; Yamamoto K; Katayama I; Sasazuki T; Lanier LL; Atsumi T; Yamada H; Arase H
    Blood; 2015 Apr; 125(18):2835-44. PubMed ID: 25733579
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical significance of phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies in systemic lupus erythematosus.
    Kaburaki J; Kuwana M; Yamamoto M; Kawai S; Matsuura E; Ikeda Y
    Lupus; 1995 Dec; 4(6):472-6. PubMed ID: 8749570
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Anti-RNP/Sm antibodies in patients with systemic lupus erythematosus and its role in thrombosis: a case-control study.
    Zamora-Medina MDC; Hinojosa-Azaola A; Nuñez-Alvarez CA; Vargas-Ruiz AG; Romero-Diaz J
    Clin Rheumatol; 2019 Mar; 38(3):885-893. PubMed ID: 30515663
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anti-annexin A5 antibodies and 25-hydroxy-cholecalciferol in female patients with primary antiphospholipid syndrome.
    Bećarević M; Sarić M; Stojanovich L; Mirković D; Dopsaj V; Ignjatović S
    Clin Rheumatol; 2018 Dec; 37(12):3359-3364. PubMed ID: 29948348
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome.
    Teixidó M; Font J; Reverter JC; Cervera R; Tàssies D; Ingelmo M; Escolar G; Ordinas A
    Br J Rheumatol; 1997 Jan; 36(1):113-6. PubMed ID: 9117149
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The role of beta 2-glycoprotein I in the antiphospholipid syndrome.
    Krilis SA; Sheng YH; Kandiah DA
    Lupus; 1996 Apr; 5(2):150-2. PubMed ID: 8743129
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Isolated anti-β2-glycoprotein I antibodies in neurology: a frontier syndrome between multiple sclerosis and antiphospholipid syndrome?
    Renaud M; Aupy J; Uring-Lambert B; Chanson JB; Collongues N; Blanc F; De Sèze J
    Eur J Neurol; 2014 Jun; 21(6):901-6. PubMed ID: 24698178
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anti-beta2-glycoprotein I antibodies.
    Tsutsumi A; Ichikawa K; Matsuura E; Koike T
    Lupus; 1998; 7 Suppl 2():S98-102. PubMed ID: 9814683
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Atheroma: links with antiphospholipid antibodies, Hughes syndrome and lupus.
    Harats D; George J; Levy Y; Khamashta MA; Hughes GR; Shoenfeld Y
    QJM; 1999 Jan; 92(1):57-9. PubMed ID: 10209673
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Value of IgA anticardiolipin and anti-beta2-glycoprotein I antibody testing in patients with pregnancy morbidity.
    Carmo-Pereira S; Bertolaccini ML; Escudero-Contreras A; Khamashta MA; Hughes GR
    Ann Rheum Dis; 2003 Jun; 62(6):540-3. PubMed ID: 12759291
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Patients with atherosclerotic syndrome, negative in anti-cardiolipin assays, make IgA autoantibodies that preferentially target domain 4 of beta2-GPI.
    Iverson GM; von Mühlen CA; Staub HL; Lassen AJ; Binder W; Norman GL
    J Autoimmun; 2006 Dec; 27(4):266-71. PubMed ID: 17081732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.